片仔癀再次蝉联投资者关系天马奖——荣获“上市公司投资者关系管理股东回报奖”

Core Viewpoint - The 16th Tianma Award ceremony, themed "Sailing Forward with New Quality Leadership," recognized Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. for its significant shareholder return performance, awarding it the "Shareholder Return Award" in investor relations management [1][3]. Group 1: Award Significance - The Tianma Award is one of the earliest evaluations focusing on investor relations management in China's capital market, aiming to enhance the management level of listed companies and showcase their investment value [3]. - This year's award emphasizes investor protection and industry-finance collaboration, aiming to establish benchmark examples that empower listed companies to demonstrate their investment value [3]. Group 2: Company Performance - Pien Tze Huang has maintained a prudent profit distribution policy, actively returning profits to shareholders, which has garnered widespread market acclaim and long-term trust from investors [3]. - The company places a high priority on investor relations management, establishing multi-level and multi-dimensional communication channels to engage with investors proactively and professionally, thereby enhancing market transparency and investor confidence [3]. Group 3: Future Plans - The company plans to continue maintaining the continuity and stability of its profit distribution policy while balancing business development and shareholder returns, aiming to enhance its ability to return value to investors [5]. - Pien Tze Huang is committed to strengthening interactions with investors and sharing the company's development achievements with its shareholders [5].